Bortezomib - NDC Database (Page 2)
35 records found
Page:
68001-534 Jul 31, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68001-540 May 16, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68001-541 Jul 31, 2022
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
70710-1411 May 02, 2022
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
70771-1708 May 02, 2022
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
70860-225 May 06, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
71288-118 Jul 26, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
72205-183 Jul 26, 2022
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC
72338-200 Jun 19, 2018
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Waverley Pharma Inc
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Waverley Pharma Inc
83090-008 Jul 15, 2023
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sintetica Us LLC
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sintetica Us LLC
83703-532 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bamboo Us Bidco Lcc
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bamboo Us Bidco Lcc
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.